| Autor: |
Bower, Katie L., Shilling, Danielle M., Bonnes, Sara L., Shah, Apeksha, Lawson, Christy M., Collier, Bryan R., Whitehead, Phyllis B. |
| Zdroj: |
Current Gastroenterology Reports; Mar2023, Vol. 25 Issue 3, p69-74, 6p |
| Abstrakt: |
Purpose of Review: Provide an evidence-based resource to inform ethically sound recommendations regarding end of life nutrition therapy. Recent Findings: • Some patients with a reasonable performance status can temporarily benefit from medically administered nutrition and hydration(MANH) at the end of life. • MANH is contraindicated in advanced dementia. • MANH eventually becomes nonbeneficial or harmful in terms of survival, function, and comfort for all patients at end of life. • Shared decision-making is a practice based on relational autonomy, and the ethical gold standard in end of life decisions. Summary: A treatment should be offered if there is expectation of benefit, but clinicians are not obligated to offer non-beneficial treatments. A decision to proceed or not should be based on the patient's values and preferences, a discussion of all potential outcomes, prognosis for given outcomes taking into consideration disease trajectory and functional status, and physician guidance provided in the form of a recommendation. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink